GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could Be Next
The Covid Era Tech Promises To Reinvent Cancer Treatment
Eli Lilly's Options: A Look at What the Big Money Is Thinking
Lilly Looking to Test Zepbound as Health Maintenance Drug: Report
Eli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight
Tradepulse Power Inflow Alert: Eli Lilly And Company Climbs 15 Points
loading...